Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wioleta M Zelek

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Seizure|June 2, 2018
Complement system biomarkers in epilepsyMaja Kopczynska, Wioleta M Zelek, Simone Vespa, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 6, 2025
Plasma complement system markers and their association with cardiometabolic risk factors: an ethnic comparison of White European and Black African menReuben M Reed, Wioleta M Zelek, B Paul Morgan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2018
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59Wioleta M Zelek, Lewis M Watkins, Owain W Howell, et al.
Journal of Neuroinflammation|February 17, 2024
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomesEleftheria Kodosaki, W John Watkins, Sam Loveless, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2020
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19Wioleta M Zelek, Jade Cole, Mark J Ponsford, et al.
Immunology|September 29, 2022
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19Matthew K Siggins, Kate Davies, Rosie Fellows, et al.
Journal of Neuroinflammation|July 21, 2023
Alzheimer's disease-associated complement gene variants influence plasma complement protein levelsAurora Veteleanu, Joshua Stevenson-Hoare, Samuel Keat, et al.
Kidney International|January 23, 2025
The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndromeKate Smith-Jackson, Patrick Walsh, Wioleta M Zelek, et al.
Acta Neuropathologica Communications|July 6, 2022
Terminal complement pathway activation drives synaptic loss in Alzheimer's disease modelsSarah M Carpanini, Megan Torvell, Ryan J Bevan, et al.
Med (New York, N.Y.)|February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravisKatherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Seizure|June 2, 2018
Complement system biomarkers in epilepsyMaja Kopczynska, Wioleta M Zelek, Simone Vespa, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 6, 2025
Plasma complement system markers and their association with cardiometabolic risk factors: an ethnic comparison of White European and Black African menReuben M Reed, Wioleta M Zelek, B Paul Morgan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2018
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59Wioleta M Zelek, Lewis M Watkins, Owain W Howell, et al.
Journal of Neuroinflammation|February 17, 2024
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomesEleftheria Kodosaki, W John Watkins, Sam Loveless, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2020
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19Wioleta M Zelek, Jade Cole, Mark J Ponsford, et al.
Immunology|September 29, 2022
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19Matthew K Siggins, Kate Davies, Rosie Fellows, et al.
Journal of Neuroinflammation|July 21, 2023
Alzheimer's disease-associated complement gene variants influence plasma complement protein levelsAurora Veteleanu, Joshua Stevenson-Hoare, Samuel Keat, et al.
Kidney International|January 23, 2025
The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndromeKate Smith-Jackson, Patrick Walsh, Wioleta M Zelek, et al.
Acta Neuropathologica Communications|July 6, 2022
Terminal complement pathway activation drives synaptic loss in Alzheimer's disease modelsSarah M Carpanini, Megan Torvell, Ryan J Bevan, et al.
Med (New York, N.Y.)|February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravisKatherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Pageof 5